Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–IVERIC bio (Nasdaq:ISEE) today announced that it will report its first quarter 2019 financial and operating results on…
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics, a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific…
– Post hoc analyses of LONHALA MAGNAIR evaluated lung function in patients with common COPD comorbidities – MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion…
− Achieved First Quarter 2019 ONPATTRO® Global Net Product Revenues of $26.3 Million with Over 400 Patients on Commercial Product…
— Trial to evaluate effects of selective inhibitor of phosphodiesterase-4D on memory and cognitive measures — GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Tetra…
Long-term efficacy and safety data for AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of migraine are the highlight of over…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, will participate…
PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics announced the appointment of Anthony Tolcher, MD, to its Scientific Advisory Board (SAB). Dr. Tolcher will provide…
Successfully Completed $70 Million Financing On Track for Multiple Data Readouts for Clinical-Stage Programs in 2019 and 2020 Management to…
DUBLIN–(BUSINESS WIRE)–The “Recombinant Protein Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…